|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/04/24 Aegon Ltd. 20-F 12/31/23 451:127M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 20-F Annual or Annual-Transition Report by a Foreign HTML 27.40M
Non-Canadian Issuer
2: EX-1.1 Underwriting Agreement or Conflict Minerals Report HTML 133K
3: EX-1.2 Underwriting Agreement or Conflict Minerals Report HTML 387K
4: EX-2.2 Plan of Acquisition, Reorganization, Arrangement, HTML 131K
Liquidation or Succession
7: EX-13 Annual or Quarterly Report to Security Holders HTML 130K
9: EX-97 Clawback Policy re: Recovery of Erroneously HTML 158K
Awarded Compensation
5: EX-12.1 Statement re: the Computation of Ratios HTML 134K
6: EX-12.2 Statement re: the Computation of Ratios HTML 135K
8: EX-15 Letter re: Unaudited Interim Financial Info HTML 129K
15: R1 Cover Page HTML 206K
16: R2 Consolidated income statement of Aegon Ltd. HTML 298K
17: R3 Consolidated statement of comprehensive income of HTML 223K
Aegon Ltd.
18: R4 Consolidated statement of financial position of HTML 294K
Aegon Ltd.
19: R5 Consolidated statement of changes in equity of HTML 294K
Aegon Ltd.
20: R6 Consolidated statement of changes in equity of HTML 131K
Aegon Ltd. (Parenthetical)
21: R7 Consolidated cash flow statement of Aegon Ltd. HTML 260K
22: R8 Consolidated cash flow statement of Aegon Ltd. HTML 135K
(Parenthetical)
23: R9 General information HTML 137K
24: R10 Material accounting policy information HTML 924K
25: R11 Investment income HTML 138K
26: R12 Critical accounting estimates and judgment in HTML 153K
applying accounting policies
27: R13 Financial risks HTML 1.95M
28: R14 Segment information HTML 1.07M
29: R15 Insurance revenue HTML 170K
30: R16 Insurance service expense HTML 153K
31: R17 Net income / (expenses) on reinsurance held HTML 150K
32: R18 Insurance Net Investment Result HTML 578K
33: R19 Other net investment result HTML 212K
34: R20 Financing net investment result HTML 154K
35: R21 Fees and commission income HTML 145K
36: R22 Other operating expenses HTML 266K
37: R23 Commissions and expenses HTML 138K
38: R24 Interest charges and related fees HTML 138K
39: R25 Other income / (Charges) HTML 137K
40: R26 Income tax HTML 226K
41: R27 Shares in group companies HTML 146K
42: R28 Earnings per share HTML 175K
43: R29 Dividend per common share HTML 134K
44: R30 Cash and cash equivalents HTML 253K
45: R31 Investments HTML 315K
46: R32 Derivatives HTML 763K
47: R33 Investments in joint ventures and associates HTML 381K
48: R34 Deferred expenses HTML 150K
49: R35 Other assets and receivables HTML 300K
50: R36 Intangible assets HTML 211K
51: R37 Shareholders' equity HTML 744K
52: R38 Other equity instruments HTML 278K
53: R39 Subordinated borrowings HTML 181K
54: R40 Trust pass-through securities HTML 153K
55: R41 Insurance contracts, reinsurance contracts held HTML 1.71M
and investment contracts with discretionary
participating features
56: R42 Investment contracts without discretionary HTML 167K
participating features
57: R43 Borrowings HTML 185K
58: R44 Provisions HTML 145K
59: R45 Defined benefit plans HTML 401K
60: R46 Deferred tax HTML 296K
61: R47 Other liabilities HTML 153K
62: R48 Accruals HTML 137K
63: R49 Capital management and solvency HTML 206K
64: R50 Fair value HTML 946K
65: R51 Commitments and contingencies HTML 164K
66: R52 Transfers of financial assets HTML 212K
67: R53 Offsetting, enforceable master netting HTML 195K
arrangements and similar agreements
68: R54 Companies and businesses acquired and divested HTML 135K
69: R55 Group companies HTML 153K
70: R56 Related party transactions HTML 161K
71: R57 Loans to group companies HTML 141K
72: R58 Non-current assets HTML 131K
73: R59 Receivables HTML 131K
74: R60 Other current assets HTML 131K
75: R61 Share capital HTML 177K
76: R62 Long-term borrowings HTML 141K
77: R63 Number of employees HTML 130K
78: R64 Auditor's remuneration HTML 150K
79: R65 Held for Sale and Discontinued Operations HTML 731K
80: R66 Comparative information 2021 HTML 884K
81: R67 Events after the reporting period HTML 132K
82: R68 Proposal for profit appropriation HTML 139K
83: R69 Summary of investments other than investments in HTML 190K
related parties
84: R70 Condensed financial information of registrant HTML 271K
85: R71 Supplementary insurance information HTML 211K
86: R72 Reinsurance HTML 151K
87: R73 Valuation and qualifying accounts HTML 157K
88: R74 Material accounting policy information (Policies) HTML 934K
89: R75 Material accounting policy information (Tables) HTML 601K
90: R76 Investment income (Tables) HTML 138K
91: R77 Financial risks (Tables) HTML 1.86M
92: R78 Segment information (Tables) HTML 1.06M
93: R79 Insurance revenue (Tables) HTML 172K
94: R80 Insurance service expense (Tables) HTML 153K
95: R81 Net income / (Expenses) on Reinsurance Held HTML 150K
(Tables)
96: R82 Insurance Net Investment Result (Tables) HTML 623K
97: R83 Other net investment result (Tables) HTML 221K
98: R84 Financing net investment result (Tables) HTML 155K
99: R85 Fees and commission income (Tables) HTML 145K
100: R86 Other operating expenses (Tables) HTML 261K
101: R87 Commissions and expenses (Tables) HTML 138K
102: R88 Interest charges and related fees (Tables) HTML 138K
103: R89 Other income / (Charges) (Tables) HTML 136K
104: R90 Income tax (Tables) HTML 228K
105: R91 Shares in group companies (Tables) HTML 145K
106: R92 Earnings per share (Tables) HTML 173K
107: R93 Cash and cash equivalents (Tables) HTML 251K
108: R94 Investments (Tables) HTML 317K
109: R95 Derivatives (Tables) HTML 753K
110: R96 Investments in joint ventures and associates HTML 384K
(Tables)
111: R97 Deferred expenses (Tables) HTML 152K
112: R98 Other assets and receivables (Tables) HTML 304K
113: R99 Intangible assets (Tables) HTML 208K
114: R100 Shareholders' equity (Tables) HTML 758K
115: R101 Other equity instruments (Tables) HTML 283K
116: R102 Subordinated borrowings (Tables) HTML 180K
117: R103 Trust pass-through securities (Tables) HTML 152K
118: R104 Insurance contracts, reinsurance contracts held HTML 1.69M
and investment contracts with discretionary
participating features (Tables)
119: R105 Investment contracts without discretionary HTML 169K
participating features (Tables)
120: R106 Borrowings (Tables) HTML 187K
121: R107 Provisions (Tables) HTML 144K
122: R108 Defined benefit plans (Tables) HTML 405K
123: R109 Deferred tax (Tables) HTML 297K
124: R110 Proposal for profit appropriation (Tables) HTML 137K
125: R111 Other liabilities (Tables) HTML 150K
126: R112 Accruals (Tables) HTML 136K
127: R113 Capital management and solvency (Tables) HTML 192K
128: R114 Fair value (Tables) HTML 887K
129: R115 Commitments and contingencies (Tables) HTML 143K
130: R116 Transfers of financial assets (Tables) HTML 206K
131: R117 Offsetting, enforceable master netting HTML 193K
arrangements and similar agreements (Tables)
132: R118 Related party transactions (Tables) HTML 152K
133: R119 Loans to group companies (Tables) HTML 141K
134: R120 Share capital (Tables) HTML 177K
135: R121 Long-term borrowings (Tables) HTML 141K
136: R122 Auditor's remuneration (Tables) HTML 147K
137: R123 Held for Sale and Discontinued Operations (Tables) HTML 811K
138: R124 Comparative information 2021 (Tables) HTML 1.47M
139: R125 General Information - Additional Information HTML 142K
(Detail)
140: R126 Material Accounting Policy Information - Summary HTML 152K
of Reconciliation Between IFRS and IFRS-EU
(Detail)
141: R127 Material Accounting Policy Information - Summary HTML 289K
of Detailed Information about Effects of Initial
Adoption of IFRS 9 and IFRS 17 on Balance Sheet
(Detail)
142: R128 Material Accounting Policy Information - Summary HTML 170K
of Detailed Information about Effects of Initial
Adoption of IFRS 9 and IFRS 17 on Earnings Per
Share (Detail)
143: R129 Material Accounting Policy Information - Summary HTML 142K
of Detailed Information about New Impairment
Allowance Measured in Accordance with the IFRS 9
(Detail)
144: R130 Material Accounting Policy Information - Summary HTML 287K
of Financial Assets and Liabilites At Date Of
Initial Application Of IFRS9 (Detail)
145: R131 Material Accounting Policy Information - Summary HTML 143K
of Financial Assets and Liabilites At Date Of
Initial Application Of IFRS9 (Parenthetical)
(Detail)
146: R132 Material Accounting Policy Information - Summary HTML 201K
of Impact of Changes in Accounting Policies on
Consolidated Financial Statements (Detail)
147: R133 Material Accounting Policy Information - HTML 189K
Additional Information (Detail)
148: R134 Investment Income - Summary of Investment Income HTML 137K
(Detail)
149: R135 Financial Risks - Schedule of Maximum Exposure to HTML 174K
Credit Risk (Detail)
150: R136 Financial Risks - Summary of Credit Risk Exposure HTML 196K
- Debt Securities (Detail)
151: R137 Financial Risks - Summary of Credit Risk Exposure HTML 168K
- Mortgages (Detail)
152: R138 Financial Risks - Additional Information (Detail) HTML 193K
153: R139 Financial Risks - Summary of Changes in Fair Value HTML 139K
have been Recognized for these Investments
(Detail)
154: R140 Financial Risks - Summary of Group Limits Per HTML 144K
Credit Rating (Detail)
155: R141 Financial Risks - Schedule of Ratings Distribution HTML 211K
of General Account Portfolios (Detail)
156: R142 Financial Risks - Summary of Credit Quality of HTML 139K
Gross Positions of Reinsurance Assets (Detail)
157: R143 Financial Risks - Schedule of Credit Risk HTML 247K
Concentration - Debt Securities and Money Market
Investments (Detail)
158: R144 Financial Risks - Schedule of Credit Risk HTML 197K
Concentration - Government Bonds (Detail)
159: R145 Financial Risks - Schedule of Credit Risk HTML 204K
Concentration - Credit Rating (Detail)
160: R146 Financial Risks - Schedule of Credit Risk HTML 162K
Concentration - Mortgage Loans (Detail)
161: R147 Financial Risks - Summary of Income Received From HTML 149K
Investments in RMBSs, SMBSs and ABSs (Detail)
162: R148 Financial Risks - Summary of information about HTML 154K
probability default rate explanatory (Detail)
163: R149 Financial Risks - Summary of Economic Variable HTML 175K
Assumptions (Detail)
164: R150 Financial Risks - Summary of Weighted Assigned to HTML 135K
Each Economic Scenario (Detail)
165: R151 Financial Risks - Summary of Reconciliation of HTML 188K
Changes in Loss Allowance - Mortgage Loans
(Detail)
166: R152 Financial Risks - Summary of Reconciliation of the HTML 138K
Loss Allowance Movements with an Impact on the
Income Statement with the Net Impairment Charge
(Detail)
167: R153 Financial Risks - Summary of Changes in the Gross HTML 192K
Carrying Amount / Market Value of the Financial
Assets - Mortgage Loans (Detail)
168: R154 Financial Risks - Summary of Changes in the Gross HTML 211K
Carrying Amount / Market Value of the Financial
Assets - Private Loans (Detail)
169: R155 Financial Risks - Summary of Equity Real Estate HTML 175K
and Other Non-fixed-income Portfolio (Detail)
170: R156 Financial Risks - Summary of Market Risk HTML 164K
Concentrations in Shares (Detail)
171: R157 Financial Risks - Summary of Closing Levels of HTML 138K
Certain Major Indices (Detail)
172: R158 Financial Risks - Summary of Sensitivity Analysis HTML 160K
of Contractual Service Margin, Net Income and
Shareholders' Equity to Equity Markets (Detail)
173: R159 Financial Risks - Schedule of Interest Rate HTML 138K
(Detail)
174: R160 Financial Risks - Schedule of Parallel Movement of HTML 147K
Yield Curve (Detail)
175: R161 Financial Risks - Summary of Exposures of HTML 136K
Non-derivative Financial Assets and Non-derivative
Liabilities (Detail)
176: R162 Financial Risks - Summary of Information on HTML 136K
Historical Net Result and Shareholders' Equity
(Detail)
177: R163 Financial Risks - Summary of Quantitative HTML 163K
Information about Financial Exposure to Currency
Risk (Detail)
178: R164 Financial Risks - Summary of Exchange Rates of US HTML 133K
Dollar and UK Pound per Euro (Detail)
179: R165 Financial Risks - Schedule of Sensitivity Analysis HTML 146K
of Net Income and Shareholders' Equity (Detail)
180: R166 Financial Risks - Summary of Maturity Analysis - HTML 188K
Insurance and Reinsurance Contracts (Detail)
181: R167 Financial Risks - Summary of Maturity Analysis - HTML 186K
Insurance and Reinsurance Contracts - Expected
Release of Risk Adjustment (Detail)
182: R168 Financial Risks - Summary of Maturity Analysis HTML 174K
Gross Undiscounted Contractual Cash Flows (Detail)
183: R169 Financial Risks - Summary of Maturity Analysis for HTML 155K
Derivative Financial Instruments (Detail)
184: R170 Segment Information - Additional Information HTML 153K
(Detail)
185: R171 Segment Information - Summary of Segment Results HTML 270K
(Detail)
186: R172 Segment Information - Summary of Segment Results HTML 130K
(Parenthetical) (Detail)
187: R173 Segment Information - Summary of Reconciliation HTML 176K
from Operating Result Before Tax to Income Before
Tax (Detail)
188: R174 Segment Information - Summary of Reconciliation HTML 142K
from Operating Result Before Tax to Income Before
Tax (Parenthetical) (Detail)
189: R175 Segment Information - Summary of Other Selected HTML 151K
Income Statement Items (Detail)
190: R176 Segment Information - Summary of Number of HTML 145K
Employees (Detail)
191: R177 Segment Information - Summary of Assets and HTML 223K
Liabilities Per Segment (Detail)
192: R178 Segment Information - Summary of Investments HTML 279K
(Detail)
193: R179 Segment Information - Summary of Detailed HTML 167K
Information About Insurance, Reinsurance and
Investment Contracts (Detail)
194: R180 Insurance Revenue - Summary of Amounts Related to HTML 158K
Changes in Liability for Remaining Coverage
(Detail)
195: R181 Insurance Revenue - Summary of Revenue Recognized HTML 145K
on Insurance and Investments Contracts (Detail)
196: R182 Insurance service expenses - Summary of Insurance HTML 150K
Service Expenses (Detail)
197: R183 Net income / (expenses) on reinsurance held - HTML 158K
Summary of net income / (Expenses) on Reinsurance
Held (Detail)
198: R184 Insurance Net Investment Result - Summary of HTML 248K
Insurance Net Investment Result (Detail)
199: R185 Insurance Net Investment Result - Summary of HTML 148K
Interest Revenue on Financial Instruments
Calculated Using the Effective Interest Method
(Detail)
200: R186 Insurance Net Investment Result - Summary of HTML 158K
Interest Revenue on Financial Instruments Measured
at Fair Value Through Profit or Loss (Detail)
201: R187 Insurance Net Investment Result - Summary of Other HTML 151K
Investment Income Explanatory (Detail)
202: R188 Insurance Net Investment Result - Summary of HTML 247K
Financial Transactions Results (Detail)
203: R189 Insurance Net Investment Result - Summary of HTML 149K
Impairment (Losses) / Reversals (Detail)
204: R190 Other Net Investment Result - Summary of Other Net HTML 141K
Investment Result (Detail)
205: R191 Other Net Investment Result - Summary Of Interest HTML 134K
Revenue On Financial Instruments Calculated Using
The Effective Interest Method (Detail)
206: R192 Other Net Investment Result - Summary Of Interest HTML 133K
Revenue On Financial Instruments Measured At Fair
Value Through Profit Or Loss (Detail)
207: R193 Other Net Investment Result - Summary Of Other HTML 133K
Investment Income Explanatory (Detail)
208: R194 Other Net Investment Result - Summary Of Results HTML 175K
From Financial Transactions (Detail)
209: R195 Other Net Investment Result - Summary of HTML 138K
Impairment Charges /(Reversals) (Detail)
210: R196 Financing Net Investment Result - Summary of HTML 143K
Financing Net Investment Result (Detail)
211: R197 Financing Net Investment Result - Summary of HTML 135K
Interest Charges (Detail)
212: R198 Fees and Commission Income - Summary of Fees and HTML 138K
Commission Income (Detail)
213: R199 Other operating expenses - Summary of Detailed HTML 164K
Information of Other Operating Expense (Detail)
214: R200 Other operating expenses - Summary of Employee HTML 142K
Expenses (Detail)
215: R201 Other operating expenses - Summary of Cumulative HTML 146K
Number of Shares Allocated (Detail)
216: R202 Other operating expenses - Summary of Cumulative HTML 184K
Number of Shares Allocated On Variable
Compensation (Detail)
217: R203 Other operating expenses - Summary of Cumulative HTML 136K
Number of Shares Allocated On Variable
Compensation (Parenthetical) (Detail)
218: R204 Commissions and Expenses - Summary of Commissions HTML 139K
and Expenses (Detail)
219: R205 Interest Charges and Related Fees - Summary of HTML 138K
Interest Charges and Related Fees (Detail)
220: R206 Other Income / (Charges) - Summary of Other HTML 133K
Charges (Detail)
221: R207 Other Income / (Charges) - Additional Information HTML 133K
(Detail)
222: R208 Income Taxes - Summary of the Components of Income HTML 169K
Tax for Period (Income) / Charge (Detail)
223: R209 Income Taxes - Summary of Reconciliation Between HTML 165K
Standard and Effective Income Tax (Detail)
224: R210 Income Taxes - Additional Information (Detail) HTML 137K
225: R211 Income Taxes - Summary of Income Tax Related to HTML 150K
Components of Other Comprehensive Income (Detail)
226: R212 Income Taxes - Summary of Income Tax Recognized HTML 133K
Directly in Retained Earnings (Detail)
227: R213 Shares in Group Companies - Summary of Shares in HTML 146K
Group Companies (Detail)
228: R214 Earnings Per Share - Summary of Basic Earnings Per HTML 178K
Share (Detail)
229: R215 Dividend Per Common Share - Additional Information HTML 165K
(Detail)
230: R216 Cash and Cash Equivalents - Summary of Detailed HTML 145K
Information about Cash and Cash Equivalents
(Detail)
231: R217 Cash and Cash Equivalents - Additional Information HTML 146K
(Detail)
232: R218 Cash and Cash Equivalents - Summary of Net Cash HTML 135K
and Cash Equivalents (Detail)
233: R219 Cash and Cash Equivalents - Disclosure of Detailed HTML 139K
Information of Cash Flow Statement (Detail)
234: R220 Cash and Cash Equivalents - Summary of HTML 161K
Reconciliation of Liabilities Arising from
Financing Activities (Detail)
235: R221 Investments - Summary of Investments for General HTML 182K
Accounts Comprise Financial Assets Excluding
Derivatives And Investments in Real Estate
(Detail)
236: R222 Investments - Summary of Financial Assets HTML 183K
Excluding Derivatives (Detail)
237: R223 Investments - Additional Information (Detail) HTML 131K
238: R224 Investments - Summary of Investments in Real HTML 146K
Estate (Detail)
239: R225 Investments - Summary of investments in real HTML 131K
estate held by entities (Detail)
240: R226 Derivatives - Summary of Derivative Asset and HTML 194K
Liability (Detail)
241: R227 Derivatives - Additional Information (Detail) HTML 144K
242: R228 Derivatives - Derivatives Not Designated In Hedge HTML 141K
(Detail)
243: R229 Derivatives - Credit Derivative Disclosure By HTML 145K
Quality (Detail)
244: R230 Derivatives - Summary of Gains Losses On Cash Flow HTML 135K
Hedge Ineffectiveness (Detail)
245: R231 Derivatives - Summary of Cash Flows are Expected HTML 149K
to Occur (Detail)
246: R232 Derivatives - Summary of Information about Terms HTML 251K
and Conditions of Hedging Instruments (Detail)
247: R233 Derivatives - Summary of Detailed Information HTML 152K
about Hedging Instruments (Detail)
248: R234 Derivatives - Summary of Detailed Information HTML 174K
About Hedged Items (Detail)
249: R235 Derivatives - Summary of Information Regarding the HTML 158K
Effectiveness of the Hedging (Detail)
250: R236 Derivatives - Summary of Nominal Amount and Fair HTML 140K
Value of Credit Derivatives (Detail)
251: R237 Investments in Joint Ventures and Associates - HTML 161K
Schedule of Investments in Joint Ventures and
Associates (Detail)
252: R238 Investments in Joint Ventures and Associates - HTML 132K
Additional information (Detail)
253: R239 Investments in Joint Ventures and Associates - HTML 235K
Summarized Financial Information of Joint Ventures
(Detail)
254: R240 Investments in Joint Ventures and Associates - HTML 161K
Summary of Overview of Summarized Financial
Information to Carrying Amount of Joint Ventures
(Detail)
255: R241 Investments in Joint Ventures and Associates - HTML 156K
Summary of Financial Information of Joint Ventures
(Detail)
256: R242 Investments in Joint Ventures and Associates - HTML 242K
Schedule of Financial Information of Associates
(Detail)
257: R243 Deferred Expenses - Summary of Amounts Arising HTML 133K
From Insurance Contracts (Detail)
258: R244 Deferred Expenses - Summary of Deferred Costs HTML 138K
Arising From Insurance Contracts (Detail)
259: R245 Other Assets and Receivables - Summary of Other HTML 138K
Assets and Receivables (Detail)
260: R246 Other Assets and Receivables - Summary of Real HTML 174K
Estate Held for Own Use and Equipment (Detail)
261: R247 Other Assets and Receivables - Additional HTML 139K
Information (Detail)
262: R248 Other Assets and Receivables - Summary of HTML 148K
Receivables (Detail)
263: R249 Other Assets and Receivables - Summary of HTML 139K
Movements in the Expected Credit Losses (Detail)
264: R250 Other Assets and Receivables - Summary of Accrued HTML 134K
Income (Detail)
265: R251 Other Assets and Receivable - Summary of HTML 172K
information about right of use assets (Detail)
266: R252 Intangible Assets - Summary of Intangible Assets HTML 183K
(Detail)
267: R253 Intangible Assets - Additional Information HTML 162K
(Detail)
268: R254 Intangible Assets - Summary of Geographically HTML 139K
Cash-Generating Units to Goodwill (Detail)
269: R255 Shareholders' Equity - Summary of Issued Share HTML 158K
Capital and Reserves Attributable to Shareholders
(Detail)
270: R256 Shareholders' Equity - Summary of Issued Share HTML 138K
Capital and Reserves Attributable to Shareholders
(Parenthetical) (Detail)
271: R257 Shareholders' Equity - Schedule of Share Capital HTML 139K
Transactions Relating To Common Shares A (Detail)
272: R258 Shareholders' Equity - Additional Information HTML 152K
(Detail)
273: R259 Shareholders' Equity - Summary of Share Capital - HTML 155K
Par Value (Detail)
274: R260 Shareholders' Equity - Summary of Share Premium HTML 136K
(Detail)
275: R261 Shareholders' Equity - Summary of Movements in the HTML 235K
Number of Treasury Common Shares (Detail)
276: R262 Shareholders' Equity - Disclosure of Share Capital HTML 134K
(Detail)
277: R263 Shareholders' Equity - Summary of Revaluation HTML 164K
Reserves (Detail)
278: R264 Shareholders' Equity - Summary of Revaluation HTML 137K
Reserve for Investments Measured at FVOCI (Detail)
279: R265 Shareholders' Equity - Summary of Remeasurement of HTML 139K
Defined Benefit Plans (Detail)
280: R266 Shareholders' Equity - Summary of Other Reserves HTML 149K
(Detail)
281: R267 Shareholders' Equity - Summary of Shareholders' HTML 299K
Equity (Detail)
282: R268 Other Equity Instruments - Summary of Other Equity HTML 168K
Instruments (Detail)
283: R269 Other Equity Instruments - Summary of Coupon HTML 151K
Details - Summary of Perpetual Contingent
Convertible (Detail)
284: R270 Other Equity Instruments - Summary of Coupon HTML 136K
Details - Summary of Perpetual Contingent
Convertible (Parenthetical) (Detail)
285: R271 Other Equity Instruments - Summary of Coupon HTML 160K
Details - Junior Perpetual Capital Securities
(Detail)
286: R272 Other Equity Instruments - Summary of Coupon HTML 157K
Details - Junior Perpetual Capital Securities
(Parenthetical) (Detail)
287: R273 Other Equity Instruments - Summary of Coupon HTML 167K
Details - Perpetual Cumulative Subordinated Bonds
(Detail)
288: R274 Other Equity Instruments - Summary of Coupon HTML 173K
Details - Perpetual Cumulative Subordinated Bonds
(Parenthetical) (Detail)
289: R275 Other Equity Instruments - Additional Information HTML 139K
(Detail)
290: R276 Subordinated Borrowings - Summary of Subordinated HTML 165K
Borrowings (Detail)
291: R277 Subordinated Borrowings - Summary of Subordinated HTML 146K
Borrowings (Parenthetical) (Detail)
292: R278 Trust Pass-Through Securities - Summary of Trust HTML 145K
Pass-through Securities (Detail)
293: R279 Trust Pass-Through Securities - Additional HTML 129K
Information (Detail)
294: R280 Insurance Contracts, Reinsurance Contracts Held HTML 152K
and Investment Contracts with Discretionary
Participating Features - Summary of Assets and
Liabilities for Groups of Insurance Contracts
Issued and Reinsurance Contracts Held by
Measurement Model (Detail)
295: R281 Insurance Contracts, Reinsurance Contracts Held HTML 312K
and Investment Contracts with Discretionary
Participating Features - Summary of Insurance
Contracts and Reinsurance Contracts by Type
(Detail)
296: R282 Insurance Contracts, Reinsurance Contracts Held HTML 169K
and Investment Contracts with Discretionary
Participating Features - Summary of Investment
Contracts with Discretionary Participating
Features (Detail)
297: R283 Insurance Contracts, Reinsurance Contracts Held HTML 427K
and Investment Contracts with Discretionary
Participating Features - Summary of Movement
Schedules by Measurement Component (Detail)
298: R284 Insurance Contracts, Reinsurance Contracts Held HTML 196K
and Investment Contracts with Discretionary
Participating Features - Summary of Contractual
Service Margin by Transition Method (Detail)
299: R285 Insurance Contracts, Reinsurance Contracts Held HTML 165K
and Investment Contracts with Discretionary
Participating Features - Summary of Maturity
Analysis Contractual Service Margin (Detail)
300: R286 Insurance Contracts, Reinsurance Contracts Held HTML 161K
and Investment Contracts with Discretionary
Participating Features - Summary of New Contracts
Recognized (Detail)
301: R287 Insurance Contracts, Reinsurance Contracts Held HTML 149K
and Investment Contracts With Discretionary
Participating Features - Summary of Investments
and Other Assets Allocated to Contracts that were
not Transitioned Fully Retrospectively (Detail)
302: R288 Insurance Contracts, Reinsurance Contracts Held HTML 156K
and Investment Contracts with Discretionary
Participating Features - Summary of Yield Curve
Used to Discount Cash Flows that do not Vary Based
on Returns on Underlying Items (Detail)
303: R289 Insurance Contracts, Reinsurance Contracts Held HTML 198K
and Investment Contracts with Discretionary
Participating Features - Summary of Detailed
Information about Illiquidity Premium Per
Portfolio (Detail)
304: R290 Insurance Contracts, Reinsurance Contracts Held HTML 168K
and Investment Contracts with Discretionary
Participating Features - Summary of Morbidity
Sensitivity has the Largest Impact and in
Aggregate (Detail)
305: R291 Insurance Contracts, Reinsurance Contracts Held HTML 237K
and Investment Contracts with Discretionary
Participating Features - Summary of Net Income and
Shareholders' Equity to Changes in Various
Underwriting Risks (Detail)
306: R292 Insurance Contracts, Reinsurance Contracts Held HTML 158K
and Investment Contracts with Discretionary
Participating Features - Summary of Net Income and
Shareholders' Equity to Changes in Various
Underwriting Risks (Parenthetical) (Detail)
307: R293 Insurance Contracts, Reinsurance Contracts Held HTML 154K
and Investment Contracts with Discretionary
Participating Features - Additional Information
(Detail)
308: R294 Investment contracts without discretionary HTML 151K
participating features - Summary of Investment
Contracts for General Account (Detail)
309: R295 Investment contracts without discretionary HTML 146K
participating features - Summary of Investment
Contracts for Account of Policyholders (Detail)
310: R296 Borrowings - Summary of Borrowings (Detail) HTML 140K
311: R297 Borrowings - Additional Information (Detail) HTML 144K
312: R298 Borrowings - Summary of Detailed Composition of HTML 152K
Capital Funding (Detail)
313: R299 Borrowings - Summary of Detailed Composition of HTML 148K
Operational Funding (Detail)
314: R300 Borrowings - Summary of Undrawn Committed HTML 134K
Borrowings Facilities (Detail)
315: R301 Provisions - Summary of Provisions (Detail) HTML 147K
316: R302 Provisions - Additional Information (Detail) HTML 137K
317: R303 Defined Benefit Plans - Summary of Defined Benefit HTML 150K
Plans (Detail)
318: R304 Defined Benefit Plans - Summary of Movements of HTML 189K
Defined Benefit Plans (Detail)
319: R305 Defined Benefit Plans - Summary of Amounts HTML 148K
Recognized in Statement of Financial Positions
(Detail)
320: R306 Defined Benefit Plans - Summary of Fair Value of HTML 143K
Plan Assets (Detail)
321: R307 Defined Benefit Plans - Summary of Breakdown of HTML 161K
Plan Assets for Retirement of Benefit Plans
(Detail)
322: R308 Defined Benefit Plans - Additional Information HTML 173K
(Detail)
323: R309 Defined Benefit Plans - Summary of Actuarial HTML 155K
Assumptions Used to Determine Defined Benefit
Obligations (Detail)
324: R310 Defined Benefit Plans - Summary of Actuarial HTML 137K
Assumptions Used to Determine Defined Benefit
Obligations (Parenthetical) (Detail)
325: R311 Defined Benefit Plans - Summary of Estimated HTML 143K
Approximate Effects on Defined Benefit Obligation
(Detail)
326: R312 Defined Benefit Plans - Estimated Approximate HTML 145K
Effects on the Defined Benefit Obligation (Detail)
327: R313 Defined Benefit Plans - Summary of Target HTML 146K
Allocation of Plan Assets for Retirement Benefit
Plans for the Next Annual Period (Detail)
328: R314 Deferred Tax - Summary of Deferred Tax (Detail) HTML 163K
329: R315 Deferred Tax - Schedule of Net Deferred Tax Assets HTML 181K
and Liabilities has been Recognized (Detail)
330: R316 Deferred Tax - Additional Information (Detail) HTML 146K
331: R317 Deferred Tax - Schedule of Loss Carryforward HTML 144K
Period and Deferred Corporate Income Tax Assets
Not Recognized (Detail)
332: R318 Deferred Tax - Summary of Deferred Corporate HTML 137K
Income Tax Asset (Detail)
333: R319 Other Liabilities - Summary of Other Liabilities HTML 157K
(Detail)
334: R320 Accruals - Summary of Accruals (Detail) HTML 133K
335: R321 Capital Management and Solvency - Additional HTML 171K
Information (Detail)
336: R322 Capital Management and Solvency - Summary of HTML 134K
Capital Ratios of Aegon's Operating Units (Detail)
337: R323 Capital Management and Solvency - Aegon's HTML 135K
Estimated Capital Position (Detail)
338: R324 Capital Management and Solvency - Composition of HTML 166K
Total Capitalization and Calculation of Gross
Financial Leverage Ratio (Detail)
339: R325 Capital Management and Solvency - Composition of HTML 131K
Total Capitalization and Calculation of Gross
Financial Leverage Ratio (Parenthetical) (Detail)
340: R326 Fair Value - Analysis of Assets and Liabilities HTML 249K
Recorded at Fair Value on Recurring Basis by Level
of Fair Value Hierarchy (Detail)
341: R327 Fair Value - Schedule of Transfers between Level 1 HTML 155K
and Level II for Financial Assets and Liabilities
Recorded at Fair Value on Recurring Basis (Detail)
342: R328 Fair Value - Disclosures of Changes in Level 3 HTML 268K
Assets (Detail)
343: R329 Fair Value - Additional Information (Detail) HTML 147K
344: R330 Fair Value - Information about Significant HTML 231K
Unobservable Inputs (Detail)
345: R331 Fair Value - Carrying Values and Estimated Fair HTML 176K
Values of Assets and Liabilities (Detail)
346: R332 Fair Value - Summary of Carrying Amounts of HTML 153K
Financial Assets and Financial Liabilities that
are Classified as at Fair Value Through Profit or
Loss (Detail)
347: R333 Fair Value - Gains and Losses Recognized in the HTML 132K
Income Statement on Financial Assets and Financial
Liabilities (Detail)
348: R334 Commitments and Contingencies - Summary of HTML 140K
Commitments through Purchase and Sale Transactions
of Investments (Detail)
349: R335 Commitments and Contingencies - Summary of Other HTML 131K
Commitments and Contingencies (Detail)
350: R336 Commitments and Contingencies - Additional HTML 171K
Information (Detail)
351: R337 Transfers of Financial Assets - Summary of HTML 149K
Carrying Amount of Financial Assets (Detail)
352: R338 Transfers of Financial Assets - Additional HTML 129K
Information (Detail)
353: R339 Transfers of Financial Assets - Summary of HTML 136K
Securities Lending (Detail)
354: R340 Transfers of Financial Assets - Summary of Reverse HTML 134K
Repurchase Agreements (Detail)
355: R341 Transfers of Financial Assets - Summary of HTML 146K
Carrying Amount of Collateral Pledged and the
Corresponding Amounts (Detail)
356: R342 Offsetting, Enforceable Master Netting HTML 170K
Arrangements and Similar Agreements - Summary of
Financial Instruments Set Off in Statement of
Financial Position (Detail)
357: R343 Companies and businesses acquired and divested - HTML 185K
Additional Information (Detail)
358: R344 Group Companies - Additional Information (Detail) HTML 209K
359: R345 Group Companies - Additional Information - HTML 162K
Associates (Detail)
360: R346 Related Party Transactions - Additional HTML 172K
Information (Detail)
361: R347 Related party transactions - Summary of HTML 152K
Remuneration Expenses (Detail)
362: R348 Related Party Transactions - Common Shares Held by HTML 135K
Board of Directors (Detail)
363: R349 Loans to Group Companies - Summary of Loans to HTML 139K
Group Companies (Detail)
364: R350 Non-current assets - Additional Information HTML 135K
(Detail)
365: R351 Receivables - Additional Information (Detail) HTML 134K
366: R352 Other Current Assets - Additional Information HTML 133K
(Detail)
367: R353 Share Capital - Detailed Information of Issued and HTML 141K
Outstanding Capital (Detail)
368: R354 Share Capital - Additional Information (Detail) HTML 131K
369: R355 Share Capital - Movement of Common Shares (Detail) HTML 150K
370: R356 Share Capital - Disclosure of Weighted Average HTML 134K
Number of Common Shares and Common Shares B
(Detail)
371: R357 Long-Term Borrowings - Summary of Long-Term HTML 144K
Borrowings (Detail)
372: R358 Long-Term Borrowings - Additional Information HTML 141K
(Detail)
373: R359 Current Liabilities - Additional Information HTML 132K
(Detail)
374: R360 Number of Employees - Additional Information HTML 131K
(Detail)
375: R361 Auditor's Remuneration - Summary of Accountants HTML 139K
Remuneration (Detail)
376: R362 Held for Sale and Discontinued Operations - HTML 218K
Summary of Income Statement of Discontinued
Operations (Detail)
377: R363 Held for Sale and Discontinued Operations - HTML 166K
Summary of Statement of Comprehensive Income
(Detail)
378: R364 Held for Sale and Discontinued Operations - HTML 168K
Additional Information (Detail)
379: R365 Held for Sale and Discontinued Operations - HTML 142K
Summary of Discontinued Operations at the Lower of
Fair Value and Carrying Amount Immediately
(Detail)
380: R366 Held for Sale and Discontinued Operations - HTML 287K
Summary of Reconciliation of Financial Instruments
(Detail)
381: R367 Held for Sale and Discontinued Operations - HTML 138K
Summary of Cash Flow from Discontinued Operations
(Detail)
382: R368 Held for Sale and Discontinued Operations - HTML 190K
Summary of Assets and Liabilities were
Reclassified as Held for Sale in Relation to the
Discontinued Operation (Detail)
383: R369 Held for Sale and Discontinued Operations - HTML 144K
Summary of Insurance Contracts (Detail)
384: R370 Held for Sale and Discontinued Operations - HTML 211K
Summary of Insurance Contract by Type (Detail)
385: R371 Held for Sale and Discontinued Operations - HTML 158K
Carrying Values and Estimated Fair Values of
Assets and Liabilities (Detail)
386: R372 Held for Sale and Discontinued Operations - HTML 200K
Summary of the Analysis of Assets and Liabilities
Recorded at Fair Value on a Recurring Basis
(Detail)
387: R373 Comparative information 2021 - Summary of HTML 158K
Reconciliation Between IFRS and IFRS-EU (Detail)
388: R374 Comparative information 2021 - Summary of HTML 139K
Information on Three Year Historical Net Income
(Loss) and Shareholders' Equity (Detail)
389: R375 Comparative information 2021 - Summary of Segment HTML 287K
Results (Detail)
390: R376 Comparative information 2021 - Summary of HTML 188K
Reconciliation from Operating Result Before Tax to
Income Before Tax (Detail)
391: R377 Comparative information 2021 - Summary of Other HTML 164K
Selected Income Statement Items (Detail)
392: R378 Comparative information 2021 - Summary of Premium HTML 139K
Income (Detail)
393: R379 Comparative information 2021 - Summary of Premiums HTML 139K
Paid to Reinsurers (Detail)
394: R380 Comparative information 2021 - Summary of HTML 145K
Investment Income (Detail)
395: R381 Comparative information 2021 - Summary of HTML 156K
Investment Income from Financial Assets (Detail)
396: R382 Comparative information 2021 - Summary of Fee and HTML 138K
Commission Income (Detail)
397: R383 Comparative information 2021 - Summary of Income HTML 138K
From Reinsurance Ceded (Detail)
398: R384 Comparative information 2021 - Summary of HTML 151K
Financial Transactions Results (Detail)
399: R385 Comparative information 2021 - Summary of Net Fair HTML 142K
Value Changes of Financial Investments at Fair
Value Through Profit or Loss, Other Than
Derivatives (Detail)
400: R386 Comparative information 2021 - Summary of Realized HTML 144K
Gains and Losses on Financial Investments (Detail)
401: R387 Comparative information 2021 - Summary of Realized HTML 138K
Gains and Losses on Financial Investment Comprise
(Detail)
402: R388 Comparative information 2021 - Summary of Net Fair HTML 139K
Value Change of Derivatives (Detail)
403: R389 Comparative information 2021 - Summary of HTML 151K
Ineffective Portion of Hedge Transactions (Detail)
404: R390 Comparative information 2021 - Summary of Net Fair HTML 141K
Value Change on for Account of Policyholder
Financial Assets at Fair Value Through Profit or
Loss (Detail)
405: R391 Comparative information 2021 - Summary of Net Fair HTML 136K
Value Change on Borrowings and Other Financial
Liabilities (Detail)
406: R392 Comparative information 2021 - Summary of Other HTML 131K
Income (Detail)
407: R393 Comparative information 2021 - Summary of HTML 148K
Policyholder Claims and Benefits (Detail)
408: R394 Comparative information 2021 - Summary of Profit HTML 135K
Sharing and Rebates (Detail)
409: R395 Comparative information 2021 - Summary of HTML 151K
Commissions and Expenses (Detail)
410: R396 Comparative information 2021 - Summary of Employee HTML 147K
Expenses (Detail)
411: R397 Comparative information 2021 - Summary of HTML 139K
Impairment Charges / (Reversals) (Detail)
412: R398 Comparative information 2021 - Summary of HTML 138K
Impairment Charges on Financial Assets, Excluding
Receivables (Detail)
413: R399 Comparative information 2021 - Summary of HTML 140K
Impairment Reversals on Financial Assets,
Excluding Receivables (Detail)
414: R400 Comparative information 2021 - Summary of Interest HTML 142K
Charges and Related Fees (Detail)
415: R401 Comparative information 2021 - Summary of Other HTML 131K
Charges (Detail)
416: R402 Comparative information 2021 - Summary of HTML 162K
Components of Income Tax for Period (Income) /
Charge (Detail)
417: R403 Comparative information 2021 - Summary of HTML 172K
Reconciliation Between Standard and Effective
Income Tax (Detail)
418: R404 Comparative information 2021 - Summary of Income HTML 165K
Tax Related to Components of Other Comprehensive
Income and Retained Earning (Detail)
419: R405 Comparative information 2021 - Summary of Basic HTML 201K
Earnings Per Share (Detail)
420: R406 Comparative information 2021 - Summary Of Gain HTML 133K
Loss On Fair Value Hedge ineffectiveness (Detail)
421: R407 Comparative information 2021 - Summary of Gains HTML 139K
Losses On Cash Flow Hedge Ineffectiveness (Detail)
422: R408 Comparative information 2021 - Summary of Issued HTML 160K
Share Capital and Reserves Attributable to
Shareholders (Detail)
423: R409 Comparative information 2021 - Summary of HTML 161K
Revaluation Reserves (Detail)
424: R410 Comparative information 2021 - Summary of HTML 137K
Revaluation Reserve for Available-for-sale
Investments (Detail)
425: R411 Comparative information 2021 - Summary of HTML 139K
Remeasurement of Defined Benefit Plans (Detail)
426: R412 Comparative information 2021 - Summary of Other HTML 154K
Reserves (Detail)
427: R413 Comparative information 2021 - Summary of HTML 160K
Remuneration Explanatory (Detail)
428: R414 Comparative information 2021 - Summary of Income HTML 213K
statement of discontinued operations (Detail)
429: R415 Comparative information 2021 - Summary of HTML 183K
Statement of Comprehensive Income (Detail)
430: R416 Comparative information 2021 - Summary of Cash HTML 143K
Flow from Discontinued Operations (Detail)
431: R417 Comparative information 2021 - Additional HTML 224K
Information (Detail)
432: R418 Comparative information 2021 - Summary of HTML 188K
supplementary insurance information for insurance
companies (Detail)
433: R419 Comparative information 2021 - Disclosure of HTML 148K
changes in reinsurance assets information (Detail)
434: R420 Comparative information 2021 - Schedule of HTML 141K
valuation and qualifying accounts (Detail)
435: R421 Events After the Reporting Period - Additional HTML 135K
Information (Detail)
436: R422 Proposal for Profit Appropriation - Additional HTML 142K
Information (Detail)
437: R423 Proposal for Profit Appropriation - Summary of HTML 136K
Proposal for Profit Appropriation (Detail)
438: R424 Schedule I - Summary of Investments Other than HTML 223K
Investments in Related Parties (Detail)
439: R425 Statement of Financial Position of Aegon Ltd. HTML 222K
(Detail)
440: R426 Condensed income statement of Aegon Ltd. (Detail) HTML 136K
441: R427 Condensed Cash Flow Statement of Aegon Ltd. HTML 161K
(Detail)
442: R428 Five-Year Schedule of Maturities of Debt (Detail) HTML 153K
443: R429 Condensed Financial Information of Registrant - HTML 133K
Additional Information (Detail)
444: R430 Schedule III - Disclosure of Supplementary HTML 175K
Insurance Information (Detail)
445: R431 Schedule IV - Summary of Reinsurance (Detail) HTML 153K
446: R432 Schedule V - Valuation and Qualifying Accounts HTML 153K
(Detail)
448: XML IDEA XML File -- Filing Summary XML 945K
451: XML XBRL Instance -- d557096d20f_htm XML 43.74M
447: EXCEL IDEA Workbook of Financial Report Info XLSX 1.25M
11: EX-101.CAL XBRL Calculations -- aeg-20231231_cal XML 715K
12: EX-101.DEF XBRL Definitions -- aeg-20231231_def XML 8.51M
13: EX-101.LAB XBRL Labels -- aeg-20231231_lab XML 8.41M
14: EX-101.PRE XBRL Presentations -- aeg-20231231_pre XML 9.02M
10: EX-101.SCH XBRL Schema -- aeg-20231231 XSD 2.11M
449: JSON XBRL Instance as JSON Data -- MetaLinks 2,029± 3.40M
450: ZIP XBRL Zipped Folder -- 0001193125-24-086614-xbrl Zip 5.81M
| EX-2.2 |
Exhibit 2.2
DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT
TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934
As of date of the Annual Report (as defined below), Aegon Ltd. (the “Company,” “we,” “us” or “our”) had the following series of securities registered pursuant to Section 12 of the U.S. Securities Exchange Act of 1934, as amended:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
| Common shares, par value EUR 0.12 per share | AEG | New York Stock Exchange | ||
| 5.500% Fixed-to-Floating Rate Subordinated Notes due 2048 | AG48 | New York Stock Exchange | ||
| 5.100% Subordinated Notes due 2049 issued by AEGON Funding Company LLC* | AEFC | New York Stock Exchange |
*Guaranteed fully and unconditionally on an unsecured subordinated basis by the Company. The Company may also substitute for AEGON Funding Company LLC (“AFC”) as the issuer of the notes on a voluntary or mandatory basis, upon certain conditions, pursuant to which AFC will be released from its obligations under the notes.
DESCRIPTION OF COMMON SHARES
The description of the Company’s common shares is hereby incorporated by reference to the descriptions that appear under the captions (i) “Description of Securities” in the prospectus dated August 17, 2023, as supplemented by the prospectus supplement dated September 19, 2023, as part of the Company’s Registration Statement on Form F-4, as amended, as filed with the U.S. Securities and Exchange Commission (the “Commission”) on July 13, 2023 (File No. 333-273041) and (ii) “Memorandum of Continuance and Bye-Laws” and “Differences between Bermuda and US companies laws” in the Company’s annual report on Form 20-F for the year ended December 31, 2023 (the “Annual Report”). The description of the Company’s Memorandum of Continuance and Bye-Laws is only a summary and does not purport to be complete and is qualified in its entirety by reference to, and should be read in conjunction with, the full text of such documents, which are filed as Exhibit 1.1 and Exhibit 1.2, respectively, to the Annual Report, and the applicable provisions of Bermuda law.
DESCRIPTION OF DEBT SECURITIES
The description of our debt securities is hereby incorporated by reference to the descriptions that appear under the captions (i) “Description of Debt Securities” in the prospectus dated August 31, 2017 and (ii) “Description of the Subordinated Notes” in the prospectus supplement dated April 4, 2018, as part of the Company’s Registration Statement on Form F-3 under the Securities Act of 1933, as amended (the “Form F-3”), as filed with the Commission on August 31, 2017 (File No. 333-220276), relating to the 5.500% fixed-to-floating rate subordinated notes due 2048.
The description of the debt securities issued by AEGON Funding Company LLC and guaranteed by the Company is hereby incorporated by reference to the descriptions that appear under the captions (i) “Description of Debt Securities” and “Description of Guarantees” in the prospectus dated August 31, 2017 and (ii) “Description of the Subordinated Notes” in the
prospectus supplement dated October 15, 2019, as part of the Form F-3, relating to the 5.10% subordinated notes due 2049.
| This ‘20-F’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/4/24 | |||
| For Period end: | 12/31/23 | |||
| 9/19/23 | 424B3 | |||
| 8/17/23 | 424B3, 425, 6-K, POS EX | |||
| 7/13/23 | F-4/A | |||
| 10/15/19 | 424B3, 6-K | |||
| 4/4/18 | 6-K, FWP | |||
| 8/31/17 | 6-K, F-3ASR | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/12/20 Aegon NV S-8 5/12/20 4:435K Donnelley … Solutions/FA 3/21/14 Aegon NV 20-F 12/31/13 11:10M Donnelley … Solutions/FA |